Ambu A/S Q4 2025 Earnings Results & Report

Ambu A/S EPS Results

• Actual EPS: $0.07
• Consensus EPS: N/A
• Beat/Miss: N/A
• One Year Ago EPS: N/A

Ambu A/S Revenue Results

• Actual Revenue: N/A
• Expected Revenue: N/A
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

Ambu A/S (OTCMKTS:AMBBY) is a Danish medical device company that develops, manufactures and markets single-use products for hospitals, clinics and emergency care providers. Its portfolio includes disposable endoscopes and visualization systems used in areas such as bronchoscopy, gastrointestinal procedures, urology, ear, nose and throat care, and anesthesia.

The company also supplies products for airway management, patient monitoring and emergency care, including electrodes, resuscitation equipment and training manikins. Ambu’s single-use products are designed to support infection prevention, simplify clinical workflows and reduce the need for reprocessing reusable equipment.

Founded in 1937, Ambu has its headquarters in Ballerup, Denmark, and serves healthcare customers internationally through operations and distribution networks across Europe, North America, the Asia-Pacific region and other global markets. The company is led by Chief Executive Officer Britt Meelby Jensen.